Calendar

If you would like to be alerted when a new event is added to this calendar, please register for the Email Alert service.

Past events

2007

2008

2009

2010

2011

2012

2013

2014

2016

2017

2018

2019

2020

2021

2022

2023

2024

24/07/2007

1st Half Year 2007 Results release

08/10/2007

Acquisition of European portfolio and sales network

14/11/2007

Q3 2007 Results Release

19/12/2007

Extraordinary AGM 2007

29/02/2008

Full-year 2007 Financial Results release

09/05/2008

Ordinary AGM 2008

21/05/2008

Laboratorios Almirall, S.A. and Forest Laboratories, Inc. to discuss aclidinium bromide data presentations at the American Thoracic Society Annual Congress

28/05/2008

Almirall at UBS Global Specialty and Generic Pharmaceutical Conference

10/06/2008

Almirall at Goldman Sachs Global Healthcare Conference, Laguna Niguel (California)

28/08/2008

Half Year 2008 Results release

15/10/2008

Follow-up to aclidinium bromide communication issued last September 3rd

12/11/2008

Q3 2008 Financial Results Release

27/02/2009

Full-year 2008 Financial Results release

02/03/2009

2008 Full-year Results Webcast

13/05/2009

Q1 2009 Financial Results release

22/05/2009

AGM 2009

09/06/2009

Almirall at Goldman Sachs Global Healthcare Conference, New York

30/07/2009

Half Year 2009 Financial Results

17/09/2009

Almirall at Bank of America/Merrill Lynch Global Healthcare Conference, London

16/11/2009

Q3 2009 Results release

12/01/2010

28th Annual JPMorgan Healthcare Conference

25/02/2010

Full Year 2009 Results

02/03/2010

Almirall at Credit Suisse Global Healthcare Conference

13/05/2010

Q1 2010 Almirall, S.A. Earnings Conference Call

14/05/2010

AGM 2010

26/05/2010

Almirall at Citi Investment Research Global Healthcare Conference, New York

02/06/2010

Almirall at 6th MedCap Conference organised by BMEX (Bolsas y Mercados Españoles), Madrid

22/06/2010

Almirall at Piper Jaffray Healthcare Conference, London

30/07/2010

Half Year 2010 Results

16/09/2010

Almirall at Bank of America/Merrill Lynch Global Healthcare Conference, London

15/11/2010

Q3 2010 Almirall, S.A. Earnings Conference Call

12/01/2011

29th Annual J.P. Morgan Healthcare Conference

28/02/2011

Full Year 2010 Results

02/03/2011

Almirall at Credit Suisse 2011 Global Healthcare Conference, London

02/03/2011

Almirall at the Citigroup 2011 Global Health Care Conference, New York

02/03/2011

Almirall at the Citigroup 2011 Global Health Care Conference, New York

06/05/2011

AGM 2011

10/05/2011

Q1 2011 Almirall SA Earnings Conference Call

15/05/2011

Almirall at the 2011 International Conference of the American Thoracic Society (ATS), Denver

07/06/2011

Almirall at Goldman Sachs Global Healthcare Conference, Los Angeles

28/07/2011

H1 2011 Results

15/09/2011

Almirall at the Bank of America / Merrill Lynch Global Healthcare Conference 2011, London

22/09/2011

Almirall at the BPI Iberian Conference, Lisbon

24/09/2011

Almirall to present additional aclinidium data at 2011 ERS Annual Congress, Amsterdam

29/09/2011

Almirall at Banesto IX Spanish Small & Mid Caps Seminar, Madrid

14/11/2011

Q3 2011 Results

10/01/2012

Almirall at JP Morgan 30th Annual Healthcare Conference, San Francisco

27/02/2012

Full year results 2011

04/05/2012

AGM 2012

08/05/2012

Q1 2012 Results

30/07/2012

Half Year 2012 Financial Results

19/10/2012

Almirall, S.A. Extraordinary Shareholder Meeting

15/11/2012

Q3 2012 Financial Results

08/01/2013

Almirall SA at JPMorgan Global Healthcare Conference

25/02/2013

Full year 2012 results

03/05/2013

Annual General Meeting

07/05/2013

First Quarter 2013 results

29/07/2013

First Half 2013 results

11/11/2013

Third Quarter 2013 results

17/12/2013

Almirall announced a webcast presentation and a conference call to detail the acquisition of Aqua Pharmaceuticals

07/03/2014

Almirall SA Extraordinary Shareholder Meeting

22/02/2016

Full Year 2015 Financial results

06/05/2016

AGM 2016

09/05/2016

First Quarter 2016 Financial Results

26/07/2016

First Half 2016 Financial results

28/07/2016

License Agreement of Tildrakizumab for Psoriasis in Europe

07/11/2016

Third Quarter 2016 Financial Results

27/02/2017

Full Year 2016 Financial Results

08/05/2017

First Quarter 2017 Financial Results

24/07/2017

First Half 2017 Financial Results

06/11/2017

Third Quarter 2017 Financial Results

26/02/2018

Full Year 2017 Financial Results

10/05/2018

AGM 2018

14/05/2018

First Quarter 2018 Financial Results

30/07/2018

First Half 2018 Financial Results

12/11/2018

Third Quarter 2018 Financial Results

07/01/2019

JP Morgan Healthcare Conference

15/01/2019

Spain Investor Day, Exane BNP Paribas Conference

25/02/2019

FY 2018 Financial Results

08/05/2019

AGM

13/05/2019

Q1 2019 Financial Results

04/06/2019

Jefferies Healthcare Conference

29/07/2019

H1 2019 Financial Results

11/11/2019

9M 2019 Financial Results

13/01/2020

JP Morgan Annual Healthcare Conference

05/02/2020

Santander Iberian Conference (Madrid)

24/02/2020

FY 2019 Financial Results

03/03/2020

Credit Suisse Healthcare Conference (London)

11/05/2020

Q1 2020 Financial Results

24/07/2020

Annual General Meeting
13:00

27/07/2020

H1 2020 Financial Results

09/11/2020

9M 2020 Financial Results

22/02/2021

FY 2020 Financial Results

10/05/2021

Q1 2021 Financial Results

26/07/2021

H1 2021 Financial Results

15/11/2021

9M 2021 Financial Results

11/01/2022

J.P. Morgan Healthcare Conference 2022

21/02/2022

FY 2021 Financial Results

30/03/2022

Lebrikizumab ADvocate 1 & 2

06/05/2022

Annual General Meeting

09/05/2022

Q1 2022 Financial Results

25/07/2022

H1 2022 Financial Results

10/11/2022

9M 2022 Financial Results

10/01/2023

41st Annual J.P. Morgan Health Care Conference

20/02/2023

Full year 2022 Financial Results

08/05/2023

Q1 2023 Financial Results

24/07/2023

H1 2023 Financial Results

09/11/2023

9M 2023 Financial Results

19/02/2024

Full year 2023 Financial Results

13/05/2024

Q1 2024 Financial Results

22/07/2024

H1 2024 Financial Results

11/11/2024

9M 2024 Financial Results